Read this company snapshot
Daily valuation snapshot
NANO-X IMAGING LTD Ordinary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.54
- Market capitalization (USD)
- $42,264,969.52
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.3
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research NNOX in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research NNOX in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing NNOX with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.54 |
| Market capitalization (USD) | $42,264,969.52 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.3 |
No matching rows. Clear the filter to see all records.
Read NNOX's valuation metrics
Company size
NANO-X IMAGING LTD Ordinary Shares's recorded market capitalization is $42,264,969.52. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
NNOX's recorded price-to-book ratio is 0.3. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research NANO-X IMAGING LTD Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about NNOX. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow NNOX's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.